Marseille, France

Nathalia Murillo

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Galderma Research & Development. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nathalia Murillo: Innovator in Rosacea Diagnosis

Introduction

Nathalia Murillo is a pioneering inventor based in Marseille, France. She has made significant contributions to the field of dermatology, particularly in the diagnosis of rosacea. Her innovative approach focuses on the characterization of specific microbiota associated with mites in rosacea patients.

Latest Patents

Nathalia holds a patent for a method for the diagnosis of rosacea. This method involves characterizing microbiota associated with mites from a rosacea patient. It includes steps such as performing a biopsy on the patient and analyzing the microbiota using techniques like 16SrRNA sequencing or pyrosequencing. Additionally, her patent describes methods for differentiating subtypes of rosacea and measuring the effectiveness of treatments on the condition.

Career Highlights

Throughout her career, Nathalia has worked with notable organizations such as Galderma Research & Development and Université d'Aix-Marseille. Her work has been instrumental in advancing the understanding and treatment of rosacea.

Collaborations

Nathalia has collaborated with esteemed colleagues, including Didier Raoult and Jérôme Aubert. Their combined expertise has contributed to the development of innovative solutions in dermatological research.

Conclusion

Nathalia Murillo's contributions to the diagnosis of rosacea highlight her role as an influential inventor in the field of dermatology. Her innovative methods and collaborations continue to pave the way for advancements in patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…